2017 Q4 Form 10-K Financial Statement
#000117184319001243 Filed on February 27, 2019
Income Statement
| Concept | 2017 Q4 | 2017 Q3 | 2017 Q2 |
|---|---|---|---|
| Revenue | $29.39M | $27.18M | $33.46M |
| YoY Change | 2.3% | 5.41% | 25.89% |
| Cost Of Revenue | $8.716M | $6.250M | $6.315M |
| YoY Change | 15.61% | 25.05% | 4.12% |
| Gross Profit | $20.17M | $20.93M | $22.03M |
| YoY Change | -2.84% | 0.69% | 7.39% |
| Gross Profit Margin | 68.63% | 76.99% | 65.82% |
| Selling, General & Admin | $6.680M | $4.823M | $4.972M |
| YoY Change | 21.68% | 12.69% | 16.85% |
| % of Gross Profit | 33.12% | 23.05% | 22.57% |
| Research & Development | $4.270M | $5.842M | $4.449M |
| YoY Change | 44.26% | 107.02% | 59.35% |
| % of Gross Profit | 21.17% | 27.91% | 20.2% |
| Depreciation & Amortization | $1.070M | $1.200M | $1.010M |
| YoY Change | 12.63% | 36.36% | 5.21% |
| % of Gross Profit | 5.31% | 5.73% | 4.59% |
| Operating Expenses | $10.94M | $10.67M | $9.421M |
| YoY Change | 29.47% | 50.17% | 33.69% |
| Operating Profit | $9.228M | $10.27M | $17.73M |
| YoY Change | -25.02% | -24.98% | 31.61% |
| Interest Expense | $140.0K | $261.0K | $16.00K |
| YoY Change | 180.0% | 180.65% | -67.35% |
| % of Operating Profit | 1.52% | 2.54% | 0.09% |
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | $9.870M | $10.53M | $17.74M |
| YoY Change | -22.83% | -23.6% | 31.25% |
| Income Tax | $4.100M | $3.643M | $6.373M |
| % Of Pretax Income | 41.54% | 34.6% | 35.92% |
| Net Earnings | $8.067M | $6.887M | $11.37M |
| YoY Change | -0.22% | -23.07% | 31.97% |
| Net Earnings / Revenue | 27.45% | 25.33% | 33.98% |
| Basic Earnings Per Share | $0.55 | $0.47 | $0.78 |
| Diluted Earnings Per Share | $0.53 | $0.46 | $0.76 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 14.58M | 14.59M | |
| Diluted Shares Outstanding | 15.14M | 15.12M | 15.04M |
Balance Sheet
| Concept | 2017 Q4 | 2017 Q3 | 2017 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $157.3M | $152.7M | $142.9M |
| YoY Change | 26.04% | 26.93% | 28.05% |
| Cash & Equivalents | $133.3M | $127.0M | $117.9M |
| Short-Term Investments | $24.00M | $25.80M | $25.00M |
| Other Short-Term Assets | $3.200M | $2.300M | $2.000M |
| YoY Change | 52.38% | 155.56% | 66.67% |
| Inventory | $22.04M | $20.25M | $17.58M |
| Prepaid Expenses | |||
| Receivables | $23.83M | $23.80M | $30.45M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $206.3M | $199.0M | $192.9M |
| YoY Change | 21.06% | 23.57% | 24.73% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $56.18M | $53.97M | $52.27M |
| YoY Change | 7.43% | 5.71% | 6.25% |
| Goodwill | $8.218M | $8.104M | $7.836M |
| YoY Change | 13.92% | 5.38% | 3.54% |
| Intangibles | $10.64M | $10.74M | $10.63M |
| YoY Change | 3.99% | -3.88% | -5.62% |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $1.254M | $1.283M | $1.400M |
| YoY Change | 1717.39% | 1183.0% | 1300.0% |
| Total Long-Term Assets | $76.29M | $74.10M | $72.12M |
| YoY Change | 9.29% | 5.87% | 5.92% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $206.3M | $199.0M | $192.9M |
| Total Long-Term Assets | $76.29M | $74.10M | $72.12M |
| Total Assets | $282.6M | $273.1M | $265.0M |
| YoY Change | 17.64% | 18.21% | 18.98% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $6.747M | $5.189M | $5.465M |
| YoY Change | 192.97% | 166.24% | 65.91% |
| Accrued Expenses | $6.326M | $6.516M | $5.673M |
| YoY Change | -2.62% | 20.15% | -14.54% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $13.07M | $11.71M | $13.44M |
| YoY Change | 48.57% | 54.24% | 27.73% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $660.0K | $545.0K | $422.0K |
| YoY Change | -68.96% | -78.68% | -64.02% |
| Total Long-Term Liabilities | $660.0K | $545.0K | $422.0K |
| YoY Change | -68.96% | -78.68% | -64.02% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $13.07M | $11.71M | $13.44M |
| Total Long-Term Liabilities | $660.0K | $545.0K | $422.0K |
| Total Liabilities | $13.73M | $12.25M | $13.86M |
| YoY Change | 25.7% | 20.75% | 18.53% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $199.5M | $191.4M | $184.6M |
| YoY Change | 18.61% | 19.56% | 22.08% |
| Common Stock | $68.76M | $66.89M | $65.32M |
| YoY Change | 11.12% | 10.53% | 9.49% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $263.5M | $253.3M | $244.1M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $282.6M | $273.1M | $265.0M |
| YoY Change | 17.64% | 18.21% | 18.98% |
Cashflow Statement
| Concept | 2017 Q4 | 2017 Q3 | 2017 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $8.067M | $6.887M | $11.37M |
| YoY Change | -0.22% | -23.07% | 31.97% |
| Depreciation, Depletion And Amortization | $1.070M | $1.200M | $1.010M |
| YoY Change | 12.63% | 36.36% | 5.21% |
| Cash From Operating Activities | $6.980M | $12.10M | $6.270M |
| YoY Change | 14.99% | 6.89% | -1111.29% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$2.470M | -$2.590M | -$2.240M |
| YoY Change | 76.43% | -5.47% | -35.07% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $1.750M | -$750.0K | -$5.750M |
| YoY Change | 0.0% | -400.0% | -1250.0% |
| Cash From Investing Activities | -$720.0K | -$3.340M | -$7.990M |
| YoY Change | -305.71% | 34.14% | 170.85% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | 100.0K | 170.0K |
| YoY Change | -100.0% | 42.86% | -254.55% |
| NET CHANGE | |||
| Cash From Operating Activities | 6.980M | 12.10M | 6.270M |
| Cash From Investing Activities | -720.0K | -3.340M | -7.990M |
| Cash From Financing Activities | 0.000 | 100.0K | 170.0K |
| Net Change In Cash | 6.260M | 8.860M | -1.550M |
| YoY Change | -2.8% | -0.45% | -57.88% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $6.980M | $12.10M | $6.270M |
| Capital Expenditures | -$2.470M | -$2.590M | -$2.240M |
| Free Cash Flow | $9.450M | $14.69M | $8.510M |
| YoY Change | 26.51% | 4.48% | 200.71% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q4 | anik |
Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
|
577000 | |
| CY2017Q4 | anik |
Accrued Clinical Trial Costs Current
AccruedClinicalTrialCostsCurrent
|
2318000 | |
| CY2018Q4 | anik |
Accrued Research Grants Current
AccruedResearchGrantsCurrent
|
400000 | |
| CY2017Q4 | anik |
Accrued Research Grants Current
AccruedResearchGrantsCurrent
|
419000 | |
| CY2018Q4 | anik |
Accrued Voluntary Recall Expenses
AccruedVoluntaryRecallExpenses
|
116000 | |
| CY2017Q4 | anik |
Accrued Voluntary Recall Expenses
AccruedVoluntaryRecallExpenses
|
||
| CY2018Q4 | anik |
Accumulated Currency Translation Adjustment
AccumulatedCurrencyTranslationAdjustment
|
-4576000 | |
| CY2017Q4 | anik |
Accumulated Currency Translation Adjustment
AccumulatedCurrencyTranslationAdjustment
|
-4132000 | |
| CY2018 | anik |
Allowance For Doubtful Accounts Receivable Translation Adjustments
AllowanceForDoubtfulAccountsReceivableTranslationAdjustments
|
-86000 | |
| CY2017 | anik |
Allowance For Doubtful Accounts Receivable Translation Adjustments
AllowanceForDoubtfulAccountsReceivableTranslationAdjustments
|
117000 | |
| CY2016 | anik |
Allowance For Doubtful Accounts Receivable Translation Adjustments
AllowanceForDoubtfulAccountsReceivableTranslationAdjustments
|
-9000 | |
| CY2018 | anik |
Buildtosuite Lease Agreement
BuildtosuiteLeaseAgreement
|
||
| CY2017 | anik |
Buildtosuite Lease Agreement
BuildtosuiteLeaseAgreement
|
||
| CY2016 | anik |
Buildtosuite Lease Agreement
BuildtosuiteLeaseAgreement
|
1723000 | |
| CY2018 | anik |
Deferred Income Tax Expense Benefit Foreign And Domestic Net
DeferredIncomeTaxExpenseBenefitForeignAndDomesticNet
|
-2347000 | |
| CY2017 | anik |
Deferred Income Tax Expense Benefit Foreign And Domestic Net
DeferredIncomeTaxExpenseBenefitForeignAndDomesticNet
|
-990000 | |
| CY2016 | anik |
Deferred Income Tax Expense Benefit Foreign And Domestic Net
DeferredIncomeTaxExpenseBenefitForeignAndDomesticNet
|
-226000 | |
| CY2018 | anik |
Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
|
800000 | |
| CY2017 | anik |
Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
|
600000 | |
| CY2016 | anik |
Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
|
600000 | |
| CY2018 | anik |
Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeduction
|
-0.013 | |
| CY2017 | anik |
Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeduction
|
0 | |
| CY2016 | anik |
Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction
EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeduction
|
0 | |
| CY2018 | anik |
Effective Income Tax Rate Reconciliation Section162 M Limitation
EffectiveIncomeTaxRateReconciliationSection162MLimitation
|
0.043 | |
| CY2017 | anik |
Effective Income Tax Rate Reconciliation Section162 M Limitation
EffectiveIncomeTaxRateReconciliationSection162MLimitation
|
0.007 | |
| CY2016 | anik |
Effective Income Tax Rate Reconciliation Section162 M Limitation
EffectiveIncomeTaxRateReconciliationSection162MLimitation
|
0.003 | |
| CY2018 | anik |
Effective Income Tax Reconciliation Nondeductible Expenses Permanent Items Percent
EffectiveIncomeTaxReconciliationNondeductibleExpensesPermanentItemsPercent
|
-0.014 | |
| CY2017 | anik |
Effective Income Tax Reconciliation Nondeductible Expenses Permanent Items Percent
EffectiveIncomeTaxReconciliationNondeductibleExpensesPermanentItemsPercent
|
0.001 | |
| CY2016 | anik |
Effective Income Tax Reconciliation Nondeductible Expenses Permanent Items Percent
EffectiveIncomeTaxReconciliationNondeductibleExpensesPermanentItemsPercent
|
0.001 | |
| CY2017Q4 | anik |
Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
|
22000000 | |
| CY2018Q4 | anik |
Inventory Raw Materials Work In Process And Finished Goods Net Of Reserve Total
InventoryRawMaterialsWorkInProcessAndFinishedGoodsNetOfReserveTotal
|
25133000 | |
| CY2017Q4 | anik |
Inventory Raw Materials Work In Process And Finished Goods Net Of Reserve Total
InventoryRawMaterialsWorkInProcessAndFinishedGoodsNetOfReserveTotal
|
22035000 | |
| CY2018Q4 | anik |
Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
|
897000 | |
| CY2018 | anik |
Percentage Of Net Revenue
PercentageOfNetRevenue
|
1 | |
| CY2017 | anik |
Percentage Of Net Revenue
PercentageOfNetRevenue
|
1 | |
| CY2016 | anik |
Percentage Of Net Revenue
PercentageOfNetRevenue
|
1 | |
| CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
| CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | |
| CY2018 | dei |
Document Type
DocumentType
|
10-K | |
| CY2019Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
14211672 | |
| CY2018 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2018Q2 | dei |
Entity Public Float
EntityPublicFloat
|
460209312 | |
| CY2018 | dei |
Entity Small Business
EntitySmallBusiness
|
false | |
| CY2018Q4 | anik |
Recall Payable
RecallPayable
|
100000 | |
| CY2018 | anik |
Schedule Of Sharebased Compensation Exercisable Stock Options And Stock Appreciation Rights Award Activity Table Text Bloc
ScheduleOfSharebasedCompensationExercisableStockOptionsAndStockAppreciationRightsAwardActivityTableTextBloc
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number<br /> Outstanding</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Avg <br /> Exercise Price</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted Average <br /> Remaining Term<br /> (in years)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Incentive stock options</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 12%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">139,674</div></td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 12%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24.53</div></td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 12%; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.1</div></td> <td style="white-space: nowrap; width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-qualified stock options</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">453,790</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40.74</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.2</div></td> <td style="white-space: nowrap; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Performance awards</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,963</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40.72</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.1</div></td> <td style="white-space: nowrap; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock appreciation rights</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">35,250</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.36</div></td> <td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.1</div></td> <td style="white-space: nowrap; text-align: left"> </td> </tr> </table></div> | |
| CY2018 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
|
8500000 | |
| CY2017 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
|
500000 | |
| CY2016 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodTotalIntrinsicValue
|
2100000 | |
| CY2017Q4 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice
|
33.70 | |
| CY2018Q4 | anik |
Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice
|
42.06 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercises In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriod
|
284548 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice
|
10.14 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Expirations In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExpirationsInPeriod
|
1079 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Expirations In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExpirationsInPeriodWeightedAverageExercisePrice
|
46.49 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeitures In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresInPeriod
|
104629 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeitures In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresInPeriodWeightedAverageExercisePrice
|
50.19 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Grants In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod
|
199970 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Grants In Period Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice
|
58.11 | |
| CY2017Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Number
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
|
1327200 | |
| CY2018Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Number
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
|
1136914 | |
| CY2018Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
42.06 | |
| CY2018 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Vested In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsVestedInPeriodFairValue
|
6700000 | |
| CY2017 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Vested In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsVestedInPeriodFairValue
|
2100000 | |
| CY2016 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Vested In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsVestedInPeriodFairValue
|
1300000 | |
| CY2018Q4 | anik |
Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Ppreciation Rights Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockPpreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
5000000 | |
| CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3392000 | |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3143000 | |
| CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6747000 | |
| CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
20775000 | |
| CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
23825000 | |
| CY2018Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
385000 | |
| CY2017Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
||
| CY2018Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
8146000 | |
| CY2017Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
6326000 | |
| CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1989000 | |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
448000 | |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
24070000 | |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
20190000 | |
| CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-5526000 | |
| CY2017Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-4784000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
50763000 | |
| CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
68617000 | |
| CY2018 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1791000 | |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3392000 | |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5807000 | |
| CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11046000 | |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
647000 | |
| CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
11046000 | |
| CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5807000 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1914000 | |
| CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
194000 | |
| CY2015Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
167000 | |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1525000 | |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1525000 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1914000 | |
| CY2018 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
360000 | |
| CY2017 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
||
| CY2016 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
||
| CY2018 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
||
| CY2017 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
6000 | |
| CY2016 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
16000 | |
| CY2018 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1000000 | |
| CY2017 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1000000 | |
| CY2016 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1100000 | |
| CY2018Q4 | us-gaap |
Assets
Assets
|
278993000 | |
| CY2017Q4 | us-gaap |
Assets
Assets
|
282617000 | |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
202943000 | |
| CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
206327000 | |
| CY2018 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
351000 | |
| CY2017 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1891000 | |
| CY2016 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1257000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14210000 | |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
89042000 | |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
133256000 | |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
104261000 | |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
110707000 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14688000 | |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
142000 | |
| CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
147000 | |
| CY2018 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-44214000 | |
| CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
28995000 | |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-6446000 | |
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
90000000 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14210000 | |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14688000 | |
| CY2017Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6315000 | |
| CY2018 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
17980000 | |
| CY2017 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
34349000 | |
| CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
31879000 | |
| CY2018 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Concentration of Credit Risk and Significant Customers</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> significant off-balance sheet risks related to foreign exchange contracts, option contracts, or other foreign hedging arrangements. The Company’s cash equivalents and investments are held with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major international financial institutions.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company, by policy, routinely assesses the financial strength of its customers. As a result, the Company believes that its accounts receivable credit risk exposure is limited.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> Mitek represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">68%,</div> respectively, of the Company’s accounts receivable balance, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other single customer accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of accounts receivable in either period.</div></div></div></div> | |
| CY2018Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
0 | |
| CY2018Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
7001000 | |
| CY2018Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8282000 | |
| CY2018Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8152000 | |
| CY2018Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
7845000 | |
| CY2017Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8716000 | |
| CY2017Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6250000 | |
| CY2017Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6083000 | |
| CY2018 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
31280000 | |
| CY2017 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
27364000 | |
| CY2016 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
24027000 | |
| CY2018 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
83806000 | |
| CY2017 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
67691000 | |
| CY2016 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
52772000 | |
| CY2017Q4 | us-gaap |
Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
|
248000 | |
| CY2018 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
4783000 | |
| CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
12608000 | |
| CY2016 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
14982000 | |
| CY2018 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
405000 | |
| CY2017 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
31000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
4769000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1500000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
740000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
1382000 | |
| CY2016 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
302000 | |
| CY2018 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
6832000 | |
| CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
15376000 | |
| CY2016 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
18549000 | |
| CY2018 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1644000 | |
| CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2737000 | |
| CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
3265000 | |
| CY2018 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-992000 | |
| CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-426000 | |
| CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-70000 | |
| CY2018 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-1203000 | |
| CY2017 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-496000 | |
| CY2016 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-72000 | |
| CY2018 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1817000 | |
| CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-1198000 | |
| CY2016 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-65000 | |
| CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
10753000 | |
| CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
10162000 | |
| CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
3542000 | |
| CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
5393000 | |
| CY2018 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-152000 | |
| CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-68000 | |
| CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-84000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7211000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
959000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
3148000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2309000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
818000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
496000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
|
363000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
|
265000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
|
2405000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
|
2743000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
3542000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
5393000 | |
| CY2018Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
8348000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
7419000 | |
| CY2017 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
349000 | |
| CY2016 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-138000 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.193 | |
| CY2018 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.05 | |
| CY2018 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
1.4 | |
| CY2018 | us-gaap |
Depreciation
Depreciation
|
4900000 | |
| CY2017 | us-gaap |
Depreciation
Depreciation
|
3300000 | |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
2700000 | |
| CY2018 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
5910000 | |
| CY2017 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4290000 | |
| CY2016 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
3734000 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.54 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.53 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.69 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.55 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.47 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.78 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.38 | |
| CY2018 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.30 | |
| CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.18 | |
| CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.22 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.54 | |
| CY2018Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.53 | |
| CY2018Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.68 | |
| CY2018Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
| CY2017Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.53 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.46 | |
| CY2017Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.76 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.37 | |
| CY2018 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.27 | |
| CY2017 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.11 | |
| CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.15 | |
| CY2018 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
29000 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.311 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.36 | |
| CY2017Q4 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.049 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0.028 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
|
0.029 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.004 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.005 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.001 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
-0.048 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
-0.002 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
|
0.001 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.055 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.048 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.045 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
|
0.002 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
|
0.007 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
|
0.001 | |
| CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.034 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.014 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
0.009 | |
| CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4446000 | |
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2893000 | |
| CY2018 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
1500000 | |
| CY2017 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
400000 | |
| CY2016 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
600000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
14439000 | |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
13439000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
1000000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
2100000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1000000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1000000 | |
| CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1000000 | |
| CY2018 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-400000 | |
| CY2017 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
700000 | |
| CY2016 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-300000 | |
| CY2018 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
371000 | |
| CY2017 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
||
| CY2016 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
||
| CY2018 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-152000 | |
| CY2017 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-150000 | |
| CY2016 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
||
| CY2018Q4 | us-gaap |
Goodwill
Goodwill
|
7851000 | |
| CY2017Q4 | us-gaap |
Goodwill
Goodwill
|
8218000 | |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
13413000 | |
| CY2017Q4 | us-gaap |
Gross Profit
GrossProfit
|
20168000 | |
| CY2017Q3 | us-gaap |
Gross Profit
GrossProfit
|
20928000 | |
| CY2017Q2 | us-gaap |
Gross Profit
GrossProfit
|
22025000 | |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
17298000 | |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
26227000 | |
| CY2018 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-367000 | |
| CY2018Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | |
| CY2018Q4 | us-gaap |
Gross Profit
GrossProfit
|
19949000 | |
| CY2018Q3 | us-gaap |
Gross Profit
GrossProfit
|
18499000 | |
| CY2018Q2 | us-gaap |
Gross Profit
GrossProfit
|
22390000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
48446000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
50181000 | |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
23207000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
46202000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
50870000 | |
| CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-3020000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-2244000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
689000 | |
| CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4485000 | |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
14386000 | |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
18323000 | |
| CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1313000 | |
| CY2016 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1582000 | |
| CY2018 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
7577000 | |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6521000 | |
| CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1738000 | |
| CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-899000 | |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1454000 | |
| CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
898000 | |
| CY2018 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
5560000 | |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
15088000 | |
| CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
22826000 | |
| CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1671000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3890000 | |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-5059000 | |
| CY2018 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2914000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2674000 | |
| CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
6201000 | |
| CY2018 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
922000 | |
| CY2017 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
367000 | |
| CY2016 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-3552000 | |
| CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1313000 | |
| CY2018Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
28206000 | |
| CY2018Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
9191000 | |
| CY2017Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
10635000 | |
| CY2018 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
1458000 | |
| CY2017 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
473000 | |
| CY2016 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
263000 | |
| CY2018Q4 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
3500000 | |
| CY2017Q4 | us-gaap |
Inventory Adjustments
InventoryAdjustments
|
1700000 | |
| CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
6819000 | |
| CY2017Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
4677000 | |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
21300000 | |
| CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
22035000 | |
| CY2018Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
3833000 | |
| CY2017Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
||
| CY2017 | us-gaap |
Inventory Recall Expense
InventoryRecallExpense
|
900000 | |
| CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
4626000 | |
| CY2017Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
6062000 | |
| CY2018 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
4419000 | |
| CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
695000 | |
| CY2016 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
654000 | |
| CY2018 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1800000 | |
| CY2017 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1800000 | |
| CY2016 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
1300000 | |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
278993000 | |
| CY2018Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
13688000 | |
| CY2017Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
11296000 | |
| CY2018Q1 | us-gaap |
Inventory Recall Expense
InventoryRecallExpense
|
1100000 | |
| CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
282617000 | |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11289000 | |
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
13073000 | |
| CY2018Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
69972000 | |
| CY2017Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
24000000 | |
| CY2018 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Nature of Business</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Anika Therapeutics, Inc. (the “Company”) is a global, integrated orthopedic and regenerative medicines company committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative tissue repair. The Company has over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> decades of global expertise developing, manufacturing, and commercializing products based on its proprietary Hyaluronic Acid (“HA”) technology. The Company’s orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company is subject to risks common to companies in the biotechnology and medical device industries including, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, development by the Company or its competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, commercialization of existing and new products, and compliance with U.S. Food and Drug Administration (“FDA”) and foreign regulations and approval requirements, as well as the ability to grow the Company’s business through appropriate commercial strategies.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At the Company’s annual stockholders’ meeting on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 31, 2018, </div>the Company’s stockholders approved an increase in the number of shares of common stock that the Company is authorized to issue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div> million to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div> million and ratified a change in the Company’s state of incorporation from the Commonwealth of Massachusetts to the State of Delaware, pursuant to a plan of domestication. The Company became a Delaware corporation with the authorization to issue up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div> million shares of its common stock on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 6, 2018. </div>Upon its domestication in Delaware, the affairs of the Company became subject to the Delaware General Corporation Law, the Company implemented a new certificate of incorporation and new bylaws, and each previously outstanding share of the Company’s common stock as a Massachusetts corporation (Anika Massachusetts) converted into an outstanding share of common stock of the Company as a Delaware corporation (Anika Delaware). The domestication was a tax-free reorganization under the U.S. Internal Revenue Code, and it did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> affect the Company’s business operations.</div></div> | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-28904000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
314000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-23993000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-50257000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-12480000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-6763000 | |
| CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
34918000 | |
| CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
40812000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
24448000 | |
| CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7717000 | |
| CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7599000 | |
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
10092000 | |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6686000 | |
| CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8067000 | |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6887000 | |
| CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11369000 | |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5493000 | |
| CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
18722000 | |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
31816000 | |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
32547000 | |
| CY2018 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2018 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
21749000 | |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
45729000 | |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
50607000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
8703000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
1879000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
414000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
1672000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
1924000 | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
1917000 | |
| CY2018Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
5800000 | |
| CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
233000 | |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
248000 | |
| CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4897000 | |
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1254000 | |
| CY2018 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-742000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2533000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-668000 | |
| CY2018 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-700000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
2500000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-700000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-668000 | |
| CY2017 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
2533000 | |
| CY2018 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-742000 | |
| CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
550000 | |
| CY2017Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
660000 | |
| CY2018 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
30000000 | |
| CY2017 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
||
| CY2016 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
25000000 | |
| CY2018 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1790000 | |
| CY2017 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
||
| CY2016 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
||
| CY2018 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
91601000 | |
| CY2017 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
45000000 | |
| CY2016 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
39249000 | |
| CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4656000 | |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8980000 | |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
14014000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1250000 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1250000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1854000 | |
| CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3211000 | |
| CY2018 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
46000000 | |
| CY2017 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
41500000 | |
| CY2016 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
46500000 | |
| CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2886000 | |
| CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
314000 | |
| CY2016 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1007000 | |
| CY2018Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
0 | |
| CY2017Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
0 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
78181000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
76373000 | |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
54111000 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
56183000 | |
| CY2018 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
57000 | |
| CY2017 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1609000 | |
| CY2016 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
52000 | |
| CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18190000 | |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18787000 | |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
10732000 | |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
218233000 | |
| CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
199511000 | |
| CY2018Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26956000 | |
| CY2018Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
26787000 | |
| CY2018Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
30548000 | |
| CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
21264000 | |
| CY2017Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
29388000 | |
| CY2017Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
27184000 | |
| CY2017Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
33462000 | |
| CY2017Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
23386000 | |
| CY2018 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
105555000 | |
| CY2017 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
113420000 | |
| CY2016 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
103379000 | |
| CY2018 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
34336000 | |
| CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
21540000 | |
| CY2016 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
18013000 | |
| CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11046000 | |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5807000 | |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3392000 | |
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
||
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
||
| CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
20.01 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
16.87 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
16.65 | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | |
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y182D | |
| CY2016 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1007000 | |
| CY2017 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
314000 | |
| CY2018 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2886000 | |
| CY2016 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
25000000 | |
| CY2018 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
30000000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
263612000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
263491000 | |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
210848000 | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
222773000 | |
| CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in; text-indent: -0.55in"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in"> </div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div> | |
| CY2018 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
247000 | |
| CY2017 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
493000 | |
| CY2016 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
434000 | |
| CY2018Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14299000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14377000 | |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14915000 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14679000 | |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15141000 | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15115000 | |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15044000 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15043000 | |
| CY2018 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14689000 | |
| CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15068000 | |
| CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15116000 | |
| CY2018Q4 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14168000 | |
| CY2018Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14237000 | |
| CY2018Q2 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14652000 | |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14679000 | |
| CY2017Q4 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14596000 | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14579000 | |
| CY2017Q2 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14588000 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
14576000 | |
| CY2018 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14442000 | |
| CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14575000 | |
| CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14682000 |
